Keros Therapeutics, Inc. (KROS)
11.32
+0.21
(+1.89%)
USD |
NASDAQ |
Sep 04, 16:00
11.31
-0.01
(-0.09%)
After-Hours: 20:00
Keros Therapeutics Cash and Short Term Investments (Annual) : 287.42M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 287.42M |
| December 31, 2024 | 559.93M |
| December 31, 2023 | 331.15M |
| December 31, 2022 | 279.05M |
| Date | Value |
|---|---|
| December 31, 2021 | 230.04M |
| December 31, 2020 | 265.88M |
| December 31, 2019 | 7.02M |
| December 31, 2018 | 23.26M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Incyte Corp. | 3.581B |
| Viking Therapeutics, Inc. | 705.74M |
| Nurix Therapeutics, Inc. | 592.94M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |